Matches in Wikidata for { <http://www.wikidata.org/entity/Q64039651> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q64039651 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q64039651 description "scientific article published on 27 March 2019" @default.
- Q64039651 description "wetenschappelijk artikel" @default.
- Q64039651 description "наукова стаття, опублікована в березні 2019" @default.
- Q64039651 name "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 name "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 type Item @default.
- Q64039651 label "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 label "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 prefLabel "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 prefLabel "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab') Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 P1433 Q64039651-95D287E0-46F2-4F0D-8461-ED1CA521578C @default.
- Q64039651 P1476 Q64039651-35745EB4-E065-4627-BEB1-913FB4212AB9 @default.
- Q64039651 P2093 Q64039651-111B92EC-2CC6-449C-A4EA-85FE5D24B281 @default.
- Q64039651 P2093 Q64039651-240B11FC-A34C-4122-8957-BD2799BCF829 @default.
- Q64039651 P2093 Q64039651-25BAD4D2-F295-4149-AECE-2392FF5A71DF @default.
- Q64039651 P2093 Q64039651-2C5E8FC8-2FF5-4D93-B06C-C0FCC60182C9 @default.
- Q64039651 P2093 Q64039651-40010AE0-A1B3-4B09-B182-745BC96F498F @default.
- Q64039651 P2093 Q64039651-4F8A96AD-F413-4CC9-BC9B-8C4EBB359BEC @default.
- Q64039651 P2093 Q64039651-77534080-C72A-4155-BFF4-35EA3EFCD4E3 @default.
- Q64039651 P2093 Q64039651-7DF4821B-D767-4A00-B7AF-711BC7F4AA1D @default.
- Q64039651 P2093 Q64039651-8ACB7F00-BD89-4A05-813B-5068BC80869F @default.
- Q64039651 P2093 Q64039651-9A03286A-2A76-441D-904D-21E10B5913C1 @default.
- Q64039651 P2093 Q64039651-E3CE8FFA-03FF-417F-8AF8-080F7AC730EC @default.
- Q64039651 P2093 Q64039651-E4A92FBD-B98C-477D-A4C5-D481A1D49A7C @default.
- Q64039651 P304 Q64039651-DC3DFE77-9901-4944-8866-D86D9D252237 @default.
- Q64039651 P31 Q64039651-3244F1F6-779C-45C6-8F4D-E912141F73E8 @default.
- Q64039651 P356 Q64039651-8AA8E8B8-446B-4F29-8269-289558244292 @default.
- Q64039651 P407 Q64039651-E5260665-2032-497B-A545-F9C6ADC5EE6F @default.
- Q64039651 P433 Q64039651-E75F2968-4146-4872-A114-1CE8B9686363 @default.
- Q64039651 P478 Q64039651-ACE78DD9-5BF8-450F-B7CB-F8BC8AD2297E @default.
- Q64039651 P50 Q64039651-2B82ADF1-7A40-46A7-AC0E-D18C56EB869B @default.
- Q64039651 P50 Q64039651-2DB11778-A1D7-4124-88E1-0C7B26A5747D @default.
- Q64039651 P50 Q64039651-8314706B-EB94-494B-A745-B1F193FE0A00 @default.
- Q64039651 P50 Q64039651-9FF8F9A9-C7C0-4D56-8516-A15C2B702E7E @default.
- Q64039651 P577 Q64039651-ED760ED8-6882-4102-AC83-D120BD0C8C0E @default.
- Q64039651 P698 Q64039651-A9ECEBDD-A55F-400D-8B56-81D0866A9A18 @default.
- Q64039651 P921 Q64039651-112B1EBC-410E-482B-B43C-A519CBD144A9 @default.
- Q64039651 P921 Q64039651-16C7DB5A-45A1-48DB-A206-5B4294735296 @default.
- Q64039651 P356 J.ANNEMERGMED.2019.02.007 @default.
- Q64039651 P698 30926190 @default.
- Q64039651 P1433 Q4767847 @default.
- Q64039651 P1476 "The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial" @default.
- Q64039651 P2093 "Christopher P Holstege" @default.
- Q64039651 P2093 "Dan Quan" @default.
- Q64039651 P2093 "Danielle Campagne" @default.
- Q64039651 P2093 "David A Meurer" @default.
- Q64039651 P2093 "Jean C Y Lo" @default.
- Q64039651 P2093 "Jude McNally" @default.
- Q64039651 P2093 "Mark Sutter" @default.
- Q64039651 P2093 "Randy I Burnham" @default.
- Q64039651 P2093 "Stephen Borron" @default.
- Q64039651 P2093 "Thomas C Arnold" @default.
- Q64039651 P2093 "Victoria E Anderson" @default.
- Q64039651 P2093 "Walter Garcia-Ubbelohde" @default.
- Q64039651 P304 "439-449" @default.
- Q64039651 P31 Q13442814 @default.
- Q64039651 P356 "10.1016/J.ANNEMERGMED.2019.02.007" @default.
- Q64039651 P407 Q1860 @default.
- Q64039651 P433 "3" @default.
- Q64039651 P478 "74" @default.
- Q64039651 P50 Q110323821 @default.
- Q64039651 P50 Q28151651 @default.
- Q64039651 P50 Q90953391 @default.
- Q64039651 P50 Q92061942 @default.
- Q64039651 P577 "2019-03-27T00:00:00Z" @default.
- Q64039651 P698 "30926190" @default.
- Q64039651 P921 Q2625993 @default.
- Q64039651 P921 Q269829 @default.